Our Pricing

Weight Loss Clinic Ipswich: Expert Prescription Treatment Services

Published: 30 September 2026

Finding a reliable weight loss clinic Ipswich residents can trust for prescription treatments like Mounjaro, Wegovy, and Saxenda is now simpler through Cured Pharmacy's fully regulated online service. Our UK-registered clinical team provides free consultations under three minutes, transparent upfront pricing from £124.99, and discreet next-day delivery across Ipswich and Suffolk. Every prescription weight loss treatment is dispensed only after clinical assessment by a qualified UK prescriber, ensuring safe, evidence-based care tailored to your health profile.

Why Choose a Weight Loss Clinic Ipswich Service Online

Accessing a weight loss clinic Ipswich service through a registered online pharmacy combines convenience with rigorous clinical standards. Traditional face-to-face clinics often require multiple appointments, long waiting times, and higher consultation fees, whereas Cured Pharmacy's digital model streamlines the process without compromising safety. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees every prescription, ensuring compliance with MHRA and GPhC regulations [1].

Patients across Ipswich benefit from the same prescription medications available through high-street pharmacies—including Mounjaro (tirzepatide), Wegovy (semaglutide), and Saxenda (liraglutide)—but with transparent pricing displayed before consultation. Clinical trials demonstrate that tirzepatide can support average weight loss of up to 15-20% of body weight over 72 weeks, while semaglutide achieves approximately 10-15% in the STEP programme [2]. All treatments require ongoing monitoring and lifestyle modifications for optimal results.

Prescription Weight Loss Treatments Available at Our Weight Loss Clinic Ipswich

Our weight loss clinic Ipswich service offers a comprehensive range of MHRA-licensed medications, each suited to different clinical profiles and budgets. Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist administered as a weekly subcutaneous injection, starting from £124.99 per pen. Clinical data from the SURPASS-2 trial showed participants lost an average of 12.4kg over 40 weeks when combined with diet and exercise [3].

Wegovy (semaglutide) injections start from £124.99 and work by mimicking the GLP-1 hormone to reduce appetite and slow gastric emptying. For patients preferring oral medication, Wegovy tablets are available from £20 offering similar efficacy without injections. Saxenda (liraglutide) is a daily injection option starting at £124.99, suitable for those who prefer more gradual dose escalation. Orlistat capsules, including branded Xenical and generic versions, start from £124.99 and work by blocking dietary fat absorption—ideal for patients seeking non-injection options [4].

Injectable vs Oral Options Through Our Weight Loss Clinic Ipswich

Injectable treatments like Mounjaro, Wegovy, and Saxenda deliver medication directly into subcutaneous tissue, ensuring consistent absorption and once-weekly (or daily) dosing. Oral alternatives such as Wegovy tablets and Orlistat capsules suit patients with needle aversion or those preferring tablet-based regimens. Our clinical team will assess your medical history, BMI, comorbidities, and personal preferences to recommend the most appropriate option during your free online consultation.

How Our Weight Loss Clinic Ipswich Online Consultation Works

Accessing our weight loss clinic Ipswich service begins with a confidential online consultation that takes under three minutes to complete. You'll provide details about your current weight, height, medical history, existing medications, and any contraindications such as thyroid disease or pancreatitis history. A UK-registered prescriber reviews your assessment within hours, ensuring treatments like Mounjaro or Wegovy are clinically appropriate and safe [5].

Once approved, your prescription is dispensed by our GPhC-registered pharmacy (9012511) and dispatched via discreet next-day delivery to any Ipswich address. All packaging is plain and unmarked, protecting your privacy. Follow-up consultations are included at no extra cost, allowing our clinical team to monitor progress, adjust dosages, and address side effects. This continuity of care mirrors traditional clinic models while offering superior convenience for busy Ipswich residents.

Eligibility Criteria for Weight Loss Clinic Ipswich Prescriptions

To qualify for prescription weight loss treatments through our weight loss clinic Ipswich service, you typically need a BMI of 30 or above, or 27+ with weight-related comorbidities such as type 2 diabetes or hypertension. Contraindications include pregnancy, breastfeeding, personal or family history of medullary thyroid carcinoma, and certain gastrointestinal disorders. Our prescribers assess each case individually, adhering to NICE guidelines and MHRA safety protocols to ensure patient suitability [6].

Clinical Evidence Supporting Weight Loss Clinic Ipswich Treatment Options

The medications available through our weight loss clinic Ipswich service are backed by extensive randomised controlled trials. The SURMOUNT-1 trial demonstrated that tirzepatide (Mounjaro) led to an average weight reduction of 15.0% at the 10mg dose and 19.5% at the 15mg dose over 72 weeks, compared to 3.1% with placebo [7]. These results position tirzepatide as one of the most effective pharmacological interventions currently licensed in the UK.

Semaglutide (Wegovy) has similarly robust evidence from the STEP trial programme, where participants achieved mean weight loss of 14.9% over 68 weeks versus 2.4% with placebo. Importantly, both medications also improved cardiovascular risk markers, including reductions in HbA1c, blood pressure, and lipid profiles [2]. Orlistat, while more modest in effect (average 2-3kg additional loss versus placebo), remains a valuable option for patients unsuitable for injectable therapies [4].

Pricing and Value at Our Weight Loss Clinic Ipswich

Transparent pricing distinguishes our weight loss clinic Ipswich service from traditional providers. Mounjaro starts at £124.99 per pen, with new patients receiving £20 off their first order using code Weightlossnew, bringing the initial cost to £124.99. Wegovy injections begin at £124.99, while oral Wegovy tablets start at £124.99. Saxenda is available from £124.99, and Orlistat options range from £124.99 to £124.99 depending on brand and pack size.

Unlike high-street clinics that bundle consultation fees separately, Cured Pharmacy includes the online prescriber assessment at no additional charge. This pricing model ensures Ipswich patients receive competitive UK rates without hidden costs. All prices are displayed upfront before consultation, allowing informed decision-making. Our lowest price guarantee means you won't find genuine UK-licensed weight loss medications cheaper elsewhere, backed by our commitment to transparent, ethical pharmacy practice.

Ongoing Costs and Treatment Duration for Weight Loss Clinic Ipswich Patients

Weight loss medications are typically prescribed for 12-24 weeks initially, with ongoing prescriptions subject to progress reviews. Mounjaro and Wegovy require weekly injections, meaning a four-pen supply covers one month. Saxenda is a daily injection, with each pen lasting approximately six days. Orlistat is taken three times daily with meals, so a 90-capsule pack provides 30 days of treatment. Our clinical team will schedule regular check-ins to assess efficacy, tolerability, and whether continued prescribing is clinically justified under NICE guidance [6].

Safety, Side Effects, and Support from Our Weight Loss Clinic Ipswich

All prescription weight loss treatments carry potential side effects, which our weight loss clinic Ipswich team discusses during consultation. GLP-1 receptor agonists like Mounjaro, Wegovy, and Saxenda commonly cause gastrointestinal symptoms—nausea, diarrhoea, constipation, and abdominal discomfort—especially during dose escalation. These effects typically diminish over 4-8 weeks as the body adapts [5]. Rare but serious risks include pancreatitis, gallbladder disease, and thyroid tumours (observed in rodent studies), necessitating careful patient selection and monitoring.

Orlistat's mechanism of blocking fat absorption can lead to oily stools, flatulence, and faecal urgency, particularly if dietary fat intake exceeds 30% of calories. Patients are advised to follow a reduced-fat diet to minimise these effects [4]. Our pharmacy team provides detailed patient information leaflets, dosing schedules, and injection technique videos for all treatments. Superintendent pharmacist Tarun Kumar and our clinical team remain available via phone (+44 116 4646009) for any concerns, ensuring continuous support throughout your weight loss journey with our weight loss clinic Ipswich service.

Scientific References

1. General Pharmaceutical Council. (2023). Standards for registered pharmacies. GPhC. [accessed 30 September 2026]
2. Wilding, J. P., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 30 September 2026]
3. Frías, J. P., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2): a randomised trial. The Lancet, 398(10295), 143-155. [accessed 30 September 2026]
4. Sjöström, L., et al. (1998). Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. The Lancet, 352(9123), 167-172. [accessed 30 September 2026]
5. Medicines and Healthcare products Regulatory Agency. (2023). GLP-1 receptor agonists: guidance for healthcare professionals. MHRA. [accessed 30 September 2026]
6. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. [accessed 30 September 2026]
7. Jastreboff, A. M., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 30 September 2026]
8. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 30 September 2026.
9. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 30 September 2026.
10. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 30 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.